MOLECULAR GENETIC SUBTYPES OF ENDOMETRIAL CANCER: MAIN POINTS AND PROGNOSTIC SIGNIFICANCE

V.K. Beloglazov¹, V.S. Levchenko¹, S.V. Gamayunov¹, ², G.A. Raskin³, V.M. Nechushkina², ⁴ 1Nizhny Novgorod Regional Clinical Oncology Dispensary, Nizhny Novgorod 2Privolzhsky Research Medical University, Nizhny Novgorod 3Medical Institute named after Berezin Sergey (MIBS), Saint Petersburg 4ANO “Scientific and Educational Center of EAFD “Eurasian Oncology Program”, Moscow Beloglazov V.K. — oncologist of the 7th Oncology Department of Oncogynecology 190, … Читать далее

MODERN APPROACHES IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER

A.A. Isimbaeva1, S.V. Zinchenko2, N.A. Shakhnazarov3, R.K. Kumisbekova1, B.T. Zhusupova1, B.A. Musabekov1 1Multi-profile Medical Center, Astana, Republic of Kazakhstan 2Kazan (Volga region) Federal University, Kazan 3Hospital of the Kazakhstan President’s office, Astana, Republic of Kazakhstan Isimbaeva A.A. – oncologist of the Chemotherapy Department 17 Manas St., Astana, 010000, Republic of Kazakhstan, e-mail: aselisimbaeva@yandex.ru, ORCID ID: 0009-0000-8305-2268 … Читать далее